Molecular biologist Andrew Holland receives President s Frontier Award
The $250,000 Johns Hopkins award recognizes scholars who are on the cusp of becoming leaders in their fields By Saralyn Cruickshank / Published Feb 15, 2021
Cell division is the fundamental process for life. But when it goes awry, life itself can be threatened.
The fragile balance of centrosomes within animal cells and the cellular functions these organelles control are essential to a form of cell division called mitosis. That s where molecular biologist Andrew Holland focuses his research. We ve been trying to understand if there are differences in the way healthy cells and tumor cells divide, and if we can exploit those differences in therapies to selectively destroy dividing tumor cells and spare the healthy cells, said Holland, an associate professor in the Department of Molecular Biology and Genetics and the Department of Oncology at the Johns Hopkins Schoo
Dr. Kenneth Freedberg was standing at his wife’s bedside in a Boston hospital’s intensive care unit when an unexpected visitor entered: Dr. Rochelle Walensky.
“We were there for no more than 45 minutes when Rochelle walks in,” said Freedberg, a professor of medicine at Harvard Medical School.
“She didn’t work there,” he said, recalling his friend Walensky’s visit after his wife had suddenly taken ill 10 years ago. “She is always there for people she is committed to, and she is committed to a lot of people.”
As the newly-appointed director of the Centers for Disease Control and Prevention (CDC), Walensky’s list of commitments has grown exponentially, a task friends and family of the Newton, Massachusetts resident agree she is uniquely prepared to handle.
Senior Healthcare Executive Tamara Elias, M.D., Joins BehaVR, Inc. Board of Directors
By
Staff
2 months ago
NASHVILLE, Tenn.–(BUSINESS WIRE)–BehaVR, a leading innovator of virtual reality-based digital wellness and digital therapeutic experiences, today announced that Tamara Elias, M.D. has been appointed to the company’s board of directors as Independent Director. Dr. Elias currently serves as Vice President and Head of Global Partnerships & Innovation at Merck & Co., Inc. Her expertise and experience will help guide BehaVR as it expands within behavioral health and works closely with health systems, payer organizations and biopharmaceutical leaders interested in this space.
Even a year into the pandemic, itâs not yet entirely clear why this is the case. Research points to a different immune response to viral exposure in children, which may signify that their immune systems are able to neutralize the virus much faster and therefore stop it from replicating. Children may also benefit from cross-protection by antibodies to other circulating coronaviruses that they are more regularly exposed to.
And thereâs also the possibility that children have fewer ACE2 receptors in the cells that line nasal passages, which are the doorways the SARS-CoV-2 viruses uses to gain entry to host cells and infect them. That would make it less likely for the virus to get a foot in the door. There is a more serious complication of SARS-CoV-2 exposure that can occur in children, called multisystem inflammatory syndrome in children, or MIS-C. However it is rare, with fewer than 1,700 cases and just 26 deaths reported across the US.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Genprex Announces Formation of Clinical Advisory Board
February 8, 2021 GMT
AUSTIN, Texas (BUSINESS WIRE) Feb 8, 2021
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the formation of a Clinical Advisory Board (CAB) to support its oncology and diabetes development programs. Comprised of preeminent clinical specialists, the CAB will lead and advise Genprex as it advances its REQORSA™ immunogene therapy program, including its Acclaim clinical trials in non-small cell lung cancer, and its preclinical diabetes gene therapy program. Some of the members also serve in additional roles at the Company.